Chemotherapy drug may be effective against COVID-19, researchers say
By
(0)
A drug used for chemotherapy, pralatrexate, also may be effective against COVID-19, researchers found. Photo by klbz/Pixabay
Dec. 31 (UPI) -- The chemotherapy drug pralatrexate, originally developed to treat lymphoma, may be effective in patients with COVID-19, according to a study published Thursday by the journal PLOS Computational Biology.
That's based on the results generated by a new computational drug screening approach created by researchers in China and lab experiments conducted by their colleagues at the Shenzhen Institutes of Advanced Technology in Shenzhen, China, the researchers said.
Advertisement
"From our data, pralatrexate is able to potently inhibit [COVID-19] replication [better] ... than remdesivir," study co-author Yanjie Wei, executive director of the Center for High Performance Computing at the Shenzhen Institutes, told UPI.